iBio, Inc. (NYSEMKT:IBIO – Get Free Report)’s share price dropped 5.5% during trading on Friday . The company traded as low as $1.16 and last traded at $1.21. Approximately 456,067 shares were traded during mid-day trading, an increase of 303% from the average daily volume of 113,212 shares. The stock had previously closed at $1.28.
iBio Price Performance
The stock’s fifty day simple moving average is $4.01 and its 200-day simple moving average is $3.07. The company has a debt-to-equity ratio of 0.04, a current ratio of 0.91 and a quick ratio of 0.91.
iBio Company Profile
iBio, Inc, a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cancer, and other diseases. The company’s technology platforms include EngageTx that provides improved CD3 T-cell engager antibody panel; ShieldTx, an antibody masking technology that enables the creation of conditionally activated antibodies; StableHu, an AI antibody-optimizing technology; and AI epitope steering technology that guides antibodies against the desired regions of the target protein.
Featured Stories
- Five stocks we like better than iBio
- 3 Best Fintech Stocks for a Portfolio Boost
- Is McDonald’s Stock Serving a Value Meal to Investors?
- What Are Dividends? Buy the Best Dividend Stocks
- Walgreens Comeback? Private Equity Circling for a Buyout
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Coca-Cola Stock Looks Refreshing After the Relief Rally
Receive News & Ratings for iBio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iBio and related companies with MarketBeat.com's FREE daily email newsletter.
